Immunomedics (IMMU) Resubmits BLA to FDA for Sacituzumab Govitecan

Go back to Immunomedics (IMMU) Resubmits BLA to FDA for Sacituzumab Govitecan

Immunomedics (IMMU) Prices 14.286M Share Common Offering at $17.50/Sh

December 5, 2019 5:51 AM EST

Immunomedics, Inc. (NASDAQ: IMMU) today announced the pricing of an... More